Skip to Content

4833M 15 850 (Metformin Hydrochloride and Pioglitazone Hydrochloride 850 mg / 15 mg)

Pill with imprint 4833M 15 850 is White, Capsule-shape and has been identified as Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg. It is supplied by Teva Pharmaceuticals USA.

Metformin/pioglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metformin/pioglitazone 850 mg / 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 4833M 15 850

Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg 4833M 15 850 Front
Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg 4833M 15 850 Back
Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg 4833M 15 850
Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg 4833M 15 850
Metformin hydrochloride and pioglitazone hydrochloride 850 mg / 15 mg 4833M 15 850

Metformin hydrochloride and pioglitazone hydrochloride

Imprint:
4833M 15 850
Strength:
850 mg / 15 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-5050

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide